Cargando…

Dissociation of Down syndrome and Alzheimer's disease effects with imaging

INTRODUCTION: Down Syndrome (DS) adults experience accumulation of Alzheimer's disease (AD)–like amyloid plaques and tangles and a high incidence of dementia and could provide an enriched population to study AD-targeted treatments. However, to evaluate effects of therapeutic intervention, it is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matthews, Dawn C., Lukic, Ana S., Andrews, Randolph D., Marendic, Boris, Brewer, James, Rissman, Robert A., Mosconi, Lisa, Strother, Stephen C., Wernick, Miles N., Mobley, William C., Ness, Seth, Schmidt, Mark E., Rafii, Michael S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Featured Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477635/ https://www.ncbi.nlm.nih.gov/pubmed/28642933 http://dx.doi.org/10.1016/j.trci.2016.02.004

Ejemplares similares

The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer’s disease biomarkers in down syndrome
por: Rafii, Michael S., et al.
Publicado: (2015)

Measurement of neurodegeneration using a multivariate early frame amyloid PET classifier
por: Matthews, Dawn C., et al.
Publicado: (2022)

FDG PET Parkinson’s disease-related pattern as a biomarker for clinical trials in early stage disease
por: Matthews, Dawn C., et al.
Publicado: (2018)

Demonstration of safety of intravenous immunoglobulin in geriatric patients in a long-term, placebo-controlled study of Alzheimer's disease
por: Gelmont, David, et al.
Publicado: (2016)

Taking down covid-19
por: Arnold, Carrie
Publicado: (2020)

Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer’s: A Multi-Modality Brain Imaging Study
por: Matthews, Dawn C., et al.
Publicado: (2014)

Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
por: Andrews, J. Scott, et al.
Publicado: (2019)

Scaling up and scaling down supply chains in volatile resource-based economies
por: Ryser, Laura, et al.
Publicado: (2021)

Stepping down
por: Marder, Eve
Publicado: (2020)

Lateral Prefrontal Cortex Subregions Make Dissociable Contributions during Fluid Reasoning
por: Hampshire, Adam, et al.
Publicado: (2011)

Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study
por: Pentz, Rowan, et al.
Publicado: (2020)

An Application of Cmaps in the Description of Clinical Information Structure and Logic in Electronic Health Records
por: Brewer, Allen, et al.
Publicado: (2012)

Development of Written Materials for Participants in an Alzheimer's Disease and Related Dementias Screening Trial
por: Head, Katharine J, et al.
Publicado: (2022)

A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community‐dwelling Mexican Americans and non‐Hispanic Whites: A method for increasing representation of diverse populations in clinical research
por: O'Bryant, Sid E., et al.
Publicado: (2021)

Estrogen activates Alzheimer's disease genes
por: Ratnakumar, Abhirami, et al.
Publicado: (2019)

From HHMI: Doubling Down on Diversity
por: Asai, David J., et al.
Publicado: (2016)

Translating Alcohol Research: Opportunities and Challenges
por: Batman, Angela M., et al.
Publicado: (2015)

Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementia
por: Matthews, Dawn C., et al.
Publicado: (2021)

Diet, psychosocial stress, and Alzheimer's disease–related neuroanatomy in female nonhuman primates
por: Frye, Brett M., et al.
Publicado: (2020)

Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum
por: Tosun, Duygu, et al.
Publicado: (2021)

Why NFC is a rising star in digital ID
por: Seth, Vikas
Publicado: (2021)

Cross-validation of optimized composites for preclinical Alzheimer's disease
por: Donohue, Michael C., et al.
Publicado: (2016)

Associations of lifestyle and vascular risk factors with Alzheimer’s brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area
por: Walters, Michelle J, et al.
Publicado: (2018)

The pattern of amyloid accumulation in the brains of adults with Down syndrome
por: Annus, Tiina, et al.
Publicado: (2016)

Multiple deadlocks in the development of nonprofit drugs
por: Cvek, Boris
Publicado: (2022)

Effects of traumatic brain injury and posttraumatic stress disorder on development of Alzheimer's disease in Vietnam Veterans using the Alzheimer's Disease Neuroimaging Initiative: Preliminary report
por: Weiner, Michael W., et al.
Publicado: (2017)

Pro: Are we ready to translate Alzheimer's disease modifying therapies to people with Down syndrome?
por: Rafii, Michael S
Publicado: (2014)

Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5
por: Papp, Kathryn V., et al.
Publicado: (2017)

The relative efficiency of time-to-progression and continuous measures of cognition in presymptomatic Alzheimer's disease
por: Li, Dan, et al.
Publicado: (2019)

Combination treatment with leptin and pioglitazone in a mouse model of Alzheimer's disease
por: Fernandez-Martos, Carmen M., et al.
Publicado: (2016)

Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer’s disease: a cross-sectional study of middle-aged adults from the broader New York City area
por: Mosconi, Lisa, et al.
Publicado: (2018)

Use of Patient Abdominal Compression Device Reduces Staff Musculoskeletal Pain Associated With Supporting Colonoscopy: Results From a Randomized Controlled Trial
por: Crockett, Seth, et al.
Publicado: (2021)

Preclinical Alzheimer's disease and longitudinal driving decline
por: Roe, Catherine M., et al.
Publicado: (2016)

Top-down response to spatial variation in productivity and bottom-up response to temporal variation in productivity in a long-term study of desert ants
por: Gibb, Heloise, et al.
Publicado: (2022)

Characterizing plasma NfL in a community‐dwelling multi‐ethnic cohort: Results from the HABLE study
por: O'Bryant, Sid, et al.
Publicado: (2021)

Detection of Alzheimer's disease amyloid beta 1‐42, p‐tau, and t‐tau assays
por: van Harten, Argonde C., et al.
Publicado: (2021)

Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
por: Ihara, Ryoko, et al.
Publicado: (2018)

Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease
por: Libiger, Ondrej, et al.
Publicado: (2021)

Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid‐life: A randomized trial
por: Hoscheidt, Siobhan, et al.
Publicado: (2021)

Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease
por: Schott, Jonathan M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fqkojie6sljfuv3roi6jscterv